# Senseonics

Eversense E3 — 荧光光学传感器，180天植入.

Source: https://cn.bioecon.ru/companies/senseonics/
Updated: 2026-07-02

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 公司认为合同制造商拥有满足需求的充足产能 | https://materials.proxyvote.com/Approved/81727U/20260326/10K_629522.PDF |
| 认证 | 获BSI认证，该机构为国际标准化组织的公告机构 | https://materials.proxyvote.com/Approved/81727U/20260326/10K_629522.PDF |
| 监管批准 | Eversense E3获FDA批准（180天）并取得CE标志（6个月）。Eversense 365已获FDA批准及CE标志。 | https://diatribe.org/diabetes-technology/180-day-implantable-cgm-eversense-e3-approved-fda, https://www.fda.gov/medical-devices/recently-approved-devices/eversense-e3-continuous-glucose-monitoring-cgm-system-p160048s021, https://www.senseonics.com/investor-relations/news-releases/2022/06-16-2022-113017038, https://www.senseonics.com/investor-relations/news-releases/2024/09-17-2024-120118174, https://www.senseonics.com/investor-relations/news-releases/2026/03-02-2026-210131962 |
| 生产基地 | 生产外包给北美与欧洲的合同制造商。 | https://materials.proxyvote.com/Approved/81727U/20260326/10K_629522.PDF |
| 营收 | 2025全年收入$3530万 | https://www.senseonics.com/investor-relations/news-releases/2026/03-02-2026-210131962 |

独立来源: diatribe.org, fda.gov, materials.proxyvote.com

## 技术

- [可穿戴生物诊断](https://cn.bioecon.ru/technology/wearable-biodiagnostics/)
- [慢性病植入式生物传感器](https://cn.bioecon.ru/technology/implantable-biosensors-chronic-disease/)